Deborah Kilpatrick, PhD is the CEO of Evidation Health, a digital health company backed by GE Ventures, Asset Management Ventures, and Rock Health. Evidation Health helps partners generate real-world evidence of digital health impact through advanced analytics of medical, behavioral and contextual data at the patient-consumer level.. Prior to her role at Evidation Health, Deborah was the Chief Commercial Officer of genomic diagnostics company CardioDx, whose Corus CAD product was named in the Wall Street Journal Technology Innovation Awards, TIME Magazine's Top 10 Medical Breakthroughs, and the Edison Awards. Earlier in her career, Deborah held multiple leadership roles at Guidant Corporation, including Research Fellow, Director of R&D, and Director of New Ventures in the Vascular Intervention Division. She serves on the Georgia Tech Advisory Board, chairs the Georgia Tech College of Engineering Advisory Board, and is a Fellow of the American Institute of Medical and Biological Engineering. Deborah is a co-founder of the MedtechVision Conference now held annually in Silicon Valley, and she has been named to FierceBiotech’s Top Women in Biotech as well as Silicon Valley Business Journal’s 100 Women of Influence. She holds B.S., M.S. and Ph.D. degrees in mechanical engineering with a bioengineering focus from Georgia Tech.
9:00 AM–10:15 AM Jun 9, 2016
Room West 3005